Perioperative hypertension in phaeochromocytoma patients undergoing adrenalectomy

• Authors: Kata Šakić , Slavica Kvolik , Marijana Grljušić , Vilena Vrbanović , Lidija Prlić
• Languages of publication: EN

Abstracts

EN

This study was designed to compare perioperative blood pressure (BP) management in hypertensive patients with phaeochromocytoma undergoing preoperative α-blockade and in patients with other suprarenal gland tumors. Perioperative hemodynamic data and immediate postoperative outcome in two groups undergoing adrenalectomy were compared. 483 medical charts from urologic patients with tumors were analyzed. In the hypertensive (n = 168) group, 20 patients with suprarenal gland tumors were identified (phaeochromocytoma n = 11, other tumors n = 9). Demographic data, intraoperative consumption of fentanyl and phentolamine, preoperative hospital stay and postoperative ICU stay were compared. Mean arterial pressure (MAP) was registered on the day before surgery, before anesthetic induction, during surgery, and upon admission in the intensive care unit (ICU). Although BP values did not differ significantly on the day before anesthesia, before induction and during operation, significantly more antihypertensive drugs were used for BP regulation in phaeochromocytoma patients versus the other tumor group. The phaeochromocytoma group required significantly more fentanyl during surgery (370±87 vs. 242±35 µg; p = 0.04). MAP upon ICU admission was significantly lower (85.1 vs. 97.4, p = 0.02) after adrenalectomy in phaeochromocytoma patients versus the other tumor group. The postoperative MAP decreased significantly in the phaeochromocytoma group (21.51 mmHg, p = 0.005), whereas significant differences according to preoperative values were not observed in the other tumor group (5.5 mmHg, p = 0.416). Prolonged preoperative hospital stay (24.6 vs. 10.0 days, p = 0.005) and ICU stay were registered in the phaeochromocytoma group. Pheochromocytoma patients had more pronounced perioperative BP oscillations, needed more antihypertensive drugs, analgesics and required prolonged hospital stay than patients with other adrenal tumors. Prolonged α-blockade may have contributed to these effects.

Keywords

EN

Surgical procedures; operative; adrenalectomy Perioperative care; Hypertension; Antihypertensive agents; Neuroendocrine tumors, phaeochromocytoma

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2007
• Volume: 2
• Issue: 4
• Pages: 470-480

Dates

published

1 - 12 - 2007

online

1 - 12 - 2007

Contributors

author

Kata Šakić

author

Slavica Kvolik

author

Marijana Grljušić

• Department of Anesthesiology, Reanimatology and Intensive Care, University Hospital Centre Rebro, Zagreb, Croatia

author

Vilena Vrbanović

• Department of Anesthesiology, Reanimatology and Intensive Care, University Hospital Centre Rebro, Zagreb, Croatia

author

Lidija Prlić

• Primary Health Care Center Osijek, Croatia

References

• [1] T. Zelinka, B. Strauch, O. Petrak, R. Holaj, A. Vrankova, H. Weisserova, K. Pacak, and J. Widimsky Jr. “Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients”, J. Hypertens., Vol. 23, (2005), pp. 2033–2039. http://dx.doi.org/10.1097/01.hjh.0000185714.60788.52[Crossref]
• [2] D.J. Myklejord: “Undiagnosed pheochromocytoma: the anesthesiologist nightmare”, Clin. Med. Res., Vol. 2, (2004), pp. 59–62.
• [3] E.L. Bravo and R. Tagle: “Pheochromocytoma: state-of-the-art and future prospects”, Endocr. Rev., Vol. 24, (2003), pp. 539–553. http://dx.doi.org/10.1210/er.2002-0013[Crossref]
• [4] K.H. Chang, T. Sugano and K. Hanaoka: “Lessons learned from anesthetic management of pheochromocytoma resection: a report of three cases” Masui., Vol. 53, (2004), pp. 1391–1395.
• [5] D.T. Williams, S. Dann and M.H. Wheeler “Phaeochromocytoma-views on current management”, Eur. J. Surg. Oncol., Vol. 29, (2003), pp. 483–490. http://dx.doi.org/10.1016/S0748-7983(03)00071-4[Crossref]
• [6] G. Lebuffe, E.D. Dosseh, G. Tek, H. Tytgat, S. Moreno, B. Tavernier: “The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas”, Anaesthesia, Vol. 60, (2005), pp. 439–944. http://dx.doi.org/10.1111/j.1365-2044.2005.04156.x[Crossref]
• [7] A. Luo, X. Guo, J. Yi, H. Ren, Y. Huang and T. Ye: “Clinical features of pheochromocytoma and perioperative anesthetic management”, Chin. Med. J., Vol. 116, (2003), pp. 1527–1531.
• [8] S.L. Chew: “Recent developments in the therapy of phaeochromocytoma”, Expert. Opin. Investig. Drugs., Vol. 13, (2004) pp. 1579–1583. http://dx.doi.org/10.1517/13543784.13.12.1579[Crossref]
• [9] S. Kocak, S. Aydintug and N. Canakci: “Alpha blockade in preoperative preparation of patients with pheochromocytomas”, Int. Surg., Vol. (87), 2002, pp. 191–194.
• [10] T.D. Atwell, C.T. Wass, J.W. Charboneau, M.R. Callstrom, M.A. Farrell and S. Sengupta: “Malignant hypertension during cryoablation of an adrenal gland tumor”, J. Vasc. Interv. Radiol., Vol. (17), 2006, pp. 573–575. http://dx.doi.org/10.1097/01.RVI.0000197370.83569.33[Crossref]
• [11] M. Guerrieri, M. Baldarelli, M. Scarpelli, S. Santini, G. Lezoche and E. Lezoche: “Laparoscopic adrenalectomy in pheochromocytomas”, J. Endocrinol. Invest., Vol. 28, (2005), pp. 523–527. [Crossref]
• [12] A.R. Boutros, E.L. Bravo, G. Zanettin and R.A. Straffon: “Perioperative management of 63 patients with pheochromocytoma”, Cleve. Clin. J. Med., Vol. 57, (1990), pp. 613–617.
• [13] G. Dugas, J. Fuller, S. Singh and J. Watson: “Pheochromocytoma and pregnancy: a case report and review of anesthetic management”, Can. J. Anaesth., Vol. 51, (2004), pp. 134–138. [Crossref]
• [14] P. Tauzin-Fin, M. Sesay, P. Gosse and P. Ballanger: “Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma”, Br. J. Anaesth., Vol. 92, (2004), pp. 512–517. http://dx.doi.org/10.1093/bja/aeh083
• [15] J.C. Ulchaker, D.A. Goldfarb, E.L. Bravo and A.C. Novick: “Successful outcomes in pheochromocytoma surgery in the modern era”, J. Urol., Vol. 161, (1999), pp. 764–767. http://dx.doi.org/10.1016/S0022-5347(01)61762-2[Crossref]
• [16] F. Sladeczek, V. Homburger, J.P. Mauger, H. Gozlan, M. Lucas, R. Bouhelal, C. Pantaloni and J. Bockaert: “Turnover of adrenergic receptors under normal and desensitized conditions”, J. Recept. Res., Vol. 4, (1984), pp.69–89.
• [17] S. Kurita, H. Tanaka, M. Sanuki, M. Kawamoto and O. Yuge: “Severe hypotension after removal of pheochromocytoma in a pediatric patient”, Masui., Vol. 51, (2002), pp. 255–260.
• [18] J. Ogata, T. Yokoyama, T. Okamoto and K. Minami: “Managing a tachyarrhythmia in a patient with pheochromocytoma with landiolol, a novel ultrashort-acting betaadrenergic blocker”, Anesth. Analg., Vol. 97, (2003), pp. 294–295. http://dx.doi.org/10.1213/01.ANE.0000067919.62656.73[Crossref]
• [19] R.C. Shupak: “Difficult anesthetic management during pheochromocytoma surgery”, J. Clin. Anesth., Vol. 11, (1999), pp. 247–250. http://dx.doi.org/10.1016/S0952-8180(99)00014-8[Crossref]
• [20] F. Combemale, B. Carnaille, B. Tavernier, M.B. Hautier, A. Thevenot, P. Scherpereel and C. Proye: “Exclusive use of calcium channel blockers and cardioselective beta-blockers in the pr e-and per-operative management of pheochromocytomas. 70 cases”, Ann. Chir., Vol. 52, (1998), 341–345.
• [21] M. Bakan, G. Kaya, S. Cakmakkaya and B. Tufanogullari: “Anesthesia management with short acting agents for bilateral pheochromocytoma removal in a 12-year-old boy”, Paediatr. Anaesth., Vol. 16, (2006), pp. 1184–1188.
• [22] M.J. Davies, D.P. McGlade and S.W. Banting: “A comparison of open and laparoscopic approaches to adrenalectomy in patients with phaeochromocytoma”, journal, Vol. 32, (2004), pp. 224–229.
• [23] W.B. Inabnet, J. Pitre, D. Bernard and Y. Chapuis: “Comparison of the hemodynamic parameters of open and laparoscopic adrenalectomy for pheochromocytoma”, World. J. Surg., Vol. 24, (2000), pp. 574–578. http://dx.doi.org/10.1007/s002689910094[Crossref]
• [24] J. Sprung, J.F. O’Hara Jr, I.S. Gill, B. Abdelmalak, A. Sarnaik and E.L. Bravo: “Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma”, Urology., Vol. 55, (2000), pp. 339–343. http://dx.doi.org/10.1016/S0090-4295(99)00466-5[Crossref]
• [25] J.L. Joris, E.E. Hamoir, G.M. Hartstein, M.R. Meurisse, B.M. Hubert, C.J. Charlier and M.L. Lamy: “Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma”, Anesth. Analg., Vol. 88, (1999), pp. 16–21. http://dx.doi.org/10.1097/00000539-199901000-00004[Crossref]
• [26] D.E. Jaroszewski, D.J. Tessier, R.T. Schlinkert, C.S. Grant, G.B. Thompson, J.A. van Heerden, D.R. Farley, S.L. Smith and R.A. Hinder: “Laparoscopic adrenalectomy for pheochromocytoma”, Mayo Clin. Proc., Vol. 78, (2003), pp. 1501–1504. http://dx.doi.org/10.4065/78.12.1501[Crossref]
• [27] L.M. Brunt, G.M. Doherty, J.A. Norton, N.J. Soper, M.A. Quasebarth and J.F. Moley: “Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms”, J. Am. Coll. Surg., Vol. 183, (1996), pp. 1–10.

Identifiers

DOI

10.2478/s11536-007-0044-0